Welcome to NewsCrafters

Shape Conversations. Effortless News Curation to Elevate Your Brand.

Latest Articles

Discover insights and stories from our community of writers

Most Active Authors (Last 30 Days):
A Night of Excellence: Edgar B. Herwick III to Illuminate the 58th Annual Bell Ringer Awards
The PR Club of New England is set to dazzle the communications world with its 58th Annual Bell Ringer Awards, presented by none other than GBH News host Edgar B. Herwick III. This prestigious ceremony, happening on June 4, 2026, at the Museum of Science in Boston, promises to honor the brightest in PR and communications.
  • Attending the Bell Ringer Awards could provide networking opportunities and industry recognition for PR professionals.
  • The 58th Annual Bell Ringer Awards will be hosted by Edgar B. Herwick III and will honor outstanding PR and communications work on June 4, 2026.
  • Proceeds from the Bell Ringers 50/50 Raffle will benefit GBH, supporting public media and enhancing community engagement.
  • The Museum of Science in Boston will be the backdrop for celebrating the achievements of the PR world.
1 min read
Read more
OS Therapies Inc.: Pioneering the Future of Osteosarcoma Treatment
OS Therapies Inc. is on the brink of revolutionizing osteosarcoma treatment with its leading therapy, OST-HER2, achieving significant clinical and regulatory milestones. With the FDA's nod and a robust pipeline poised for commercial launch, OS Therapies is setting a new standard in a field that hasn't seen innovation in over four decades.
  • Investing in OS Therapies Inc. offers a competitive edge with its pioneering osteosarcoma treatment and potential for dramatic stock re-ratings.
  • Stonegate Capital Partners has begun covering OS Therapies Inc., highlighting its clinical, regulatory, and financial progress, and anticipating a U.S. launch in 2026.
  • OS Therapies Inc.'s advancement in osteosarcoma treatment represents a significant leap forward in cancer therapy, offering hope to patients with few options.
  • OS Therapies is not just for humans; their subsidiary, OS Animal Health, is bringing their cancer therapy to dogs with positive trial results.
1 min read
Read more